‘A wake-up call’: GPs issued warning over semaglutide prescribing The DoHAC has delivered ‘education letters’ to more than 1000 doctors found to be prescribing the medication under the PBS, but failing to follow the criteria.
Examining the pros and cons of semaglutide A new study finds lowered risk of 42 health outcomes and increased risk of 19 for people using GLP-1RAs, highlighting the ‘far-reaching potential’ of the drugs.
Sweeping change needed amid ‘diabetes epidemic’: Inquiry The RACGP says prevention is key, as Medicare reform, bolstered rural access, sugar taxes, and CGM subsidies were all recommended.
Replica Ozempic and Mounjaro to be banned The Government has removed a loophole allowing the mass production of the compounded drugs amid growing patient safety concerns.